NAM logo

  • site map
  • contact
  • advanced search

  • home
  • news
  • treatment & care
  • hiv worldwide
  • living with hiv
  • preventing hiv
  • organisations
  • hiv basics
  • about us

Aidsmap

key topic guides


  • Russian
  • Romanian
  • Français
  • Português
  • Español

YOU ARE HERE:
  • > home
  • >> Key topic guides
Starting treatment
Information on the choice of first-line therapy to treat HIV infection, including when to start, what to start with, and clinical trials for people who have never taken antiretroviral therapy.
News
  Landmark study shows why AZT/3TC/efavirenz now preferred as first-line HIV treatment
  Better clinical outcomes if HAART started before CD4 cell count falls below 200
  More evidence that earlier treatment provides greatest benefit for children with HIV
  HIV patients with severe immune damage have incomplete immune recovery - but does it matter?
  French HIV-2 cohort study: treat only when plasma viral load can be measured.
Patient Information
  Drug diary
  Late drug doses
  Primary infection
Treatment & Care
  Alternative & complementary therapies
  Choosing a combination
  Choosing your treatment strategy
  Discordant CD4 cell count and viral load responses
  Immune restoration illnesses
  Initial regimens in resource-limited settings
  Prophylaxis and immune recovery
  Resistance testing to select treatment
  Starting treatment
  UK trials for people new to treatment
  When to start treatment
AIDS Treatment Update
  No Nukes?


key topic guides

  • Key topic guides
  • News categories
  • Links categories

other key topic guides

  • Adherence
  • Africa
  • Asia and Pacific
  • Changing treatment
  • Children and HIV
  • Conference reports
  • Developed world
  • Eastern Europe and Russia
  • Hepatitis
  • HIV and Cancer
  • HIV and drug use
  • HIV and sexual health
  • Latin America
  • Lipodystrophy
  • Medical tests
  • Mental health
  • Middle East
  • New drugs
  • News Features
  • Palliative care
  • Recently diagnosed
  • Resistance
  • Salvage treatment
  • Side-effects
  • Starting treatment
  • Statistics and epidemiology
  • Treatment access
  • Treatment interruptions
  • Tuberculosis
  • UK policy
  • Vaccines
  • Women and HIV


Support our work today




  • contact
  • email update
  • disclaimer
  • copyright